ArticleDiabetes/metabolism research and reviews2026
Serum Bone-, Muscle- and Fat- Derived Factors Sclerostin, Irisin and Leptin Show Different Correlations With Body Composition and Bone Mineral Density in Chinese Men With Obesity: A Cross-Sectional Study.
Article in Diabetes/metabolism research and reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsThis study aimed to explore the interactions among sclerostin, irisin and leptin, as well as their associations with body composition and bone metabolism in Chinese men with obesity. MATERIALS AND
methodsThis study included 26 men with normal weight and 78 men with obesity. Body composition was measured using dual-emission X-ray absorptiometry. Subcutaneous fat, visceral fat and fat content in the liver and pancreas were determined by magnetic resonance. Serum sclerostin, irisin and leptin were detected using the Elisa assay.
resultsCompared with men with normal weight, serum sclerostin, irisin and leptin levels as well as whole-body and spinal bone mineral density were increased, whereas pelvic bone mineral density was not different in men with obesity. Partial analysis showed that in men with obesity, serum sclerostin was positively correlated with bone mineral density but not with body composition; serum irisin was positively correlated with fat mass percent, negatively correlated with muscle mass percent, but not with bone mineral density; serum leptin was positively correlated with fat mass, while negatively associated with muscle mass and bone mineral density. Furthermore, body weight showed beneficial effects on whole-body and spinal bone, whereas central fat distribution exerted adverse effects on pelvic bone. Stepwise linear regression revealed that serum sclerostin and whole-body muscle mass were independent predictors of bone mineral density in the over-all cohort.
conclusionsSerum sclerostin, irisin and leptin show distinct correlations with body composition and bone mineral density in men with obesity, which may partly reflect the complex effects of obesity on bone metabolism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.